Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Net loss	$ (4,843,383)	$ (2,593,659)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	292,070	365,770
Amortization of deferred compensation	3,566	3,566
Stock compensation expense	95,646	166,314
Deferred Income Tax Expense (Benefit)	0	(500,000)
Change in assets and liabilities:
Accounts receivable, net	1,518,752	2,628,036
Inventories	1,919,925	256,939
Recoverable income taxes	0	92,811
Prepaid expenses and other current assets	216,604	(213,579)
Other assets	13,617	184,147
Accounts payable	(837,611)	(838,632)
Accrued compensation and employee benefits	(412,377)	(513,112)
Accrued expenses	(12,920)	(101,514)
Unearned revenue	(51,053)	(120,263)
Other liabilities	(130,228)	(127,179)
Net cash provided by (used in)	(2,227,392)	(1,310,355)
Cash flows from investing activities:
Increase (Decrease) in Trading Securities	(2,355)	279,505
Payments to Acquire Property, Plant, and Equipment	(116,932)	(3,773,134)
Net Cash Provided by (Used in) Investing Activities	(119,287)	(3,493,629)
Net Cash Provided by (Used in) Financing Activities [Abstract]
Effect of Exchange Rate on Cash and Cash Equivalents	31,134	(2,554)
Cash and Cash Equivalents, Period Increase (Decrease)	(2,315,545)	(4,806,538)
Cash at beginning of year	8,281,714	6,234,268
Cash at end of period	$ 5,966,169	$ 1,427,730